1 | FPLCA, OSMR
|
| A novel missense mutation in oncostatin M receptor beta causing primary localized cutaneous amyloidosis.
|
| Saeedi M, Ebrahim-Habibi A, Haghighi A, Zarrabi F, Amoli MM, Robati RM.
|
| Biomed Res Int 2014:653724. doi: 10.1155/2014/653724. Epub 2014 Jun 26.
2014
|
2 | FPLCA, OSMR
|
| The molecular skin pathology of familial primary localized cutaneous amyloidosis.
|
| Tanaka A, Lai-Cheong JE, van den Akker PC, Nagy N, Millington G, Diercks GF, van Voorst Vader PC, Clements SE, Almaani N, Techanukul T, Hide M, South AP, McGrath JA.
|
| Exp Dermatol 19(5):416-23. doi: 10.1111/j.1600-0625.2010.01083.x.
2010
|
3 | FPLCA, OSMR
|
| Oncostatin M Receptor-beta Mutations Underlie Familial Primary Localized Cutaneous Amyloidosis.
|
| Arita K, South AP, Hans-Filho G, Sakuma TH, Lai-Cheong J, Clements S, Odashiro M, Odashiro DN, Hans-Neto G, Hans NR, Holder MV, Bhogal BS, Hartshorne ST, Akiyama M, Shimizu H, McGrath JA.
|
| Am J Hum Genet 82(1):73-80. 2008
|
4 | FPLCA
|
| Genome-wide scan identifies a susceptibility locus for familial primary cutaneous amyloidosis on chromosome 5p13.1-q11.2.
|
| Lee DD, Lin MW, Chen IC, Huang CY, Liu MT, Wang CR, Chang YT, Liu HN, Liu TT, Wong CK, Tsai SF.
|
| Br J Dermatol 155(6):1201-8.
2006
|